Categories
Cardiovascular
Diagnostics
Endocrinology
Health Insurance
Medical Devices
Mental Health
Nutrition
Oncology
Public Health
Sexual Health
Popular Articles

Maryland Reports First H1N1 Flu-Related Death, USA
An elderly Baltimore metro area resident with serious underlying medical conditions and a novel H1N1 influenza virus infection has died, according to the Department of Health and Mental Hygiene (DHMH). Among other complications, H1N1 flu was a contributing factor, making this Maryland"s first death confirmed to be associated with the novel flu strain. Personal details about the case, including specific underlying health conditions, will not be released to protect the privacy of the resident and the resident"s family.
generic viagra online
Change4Life Corner Shops To Open Across The Country, UK
Corner shops nationwide will get help from Change4Life to sell fruit and veg - this will mean more people will get their 5 a day and shops will see an increase in profits, Secretary of State for Health Andy Burnham said today.
News of the day
India To Provide Incentives For Medical Professionals To Work In Rural, Underserved Areas
In an effort to encourage medical professionals to provide services to low-income rural populations in India, Union Health and Family Welfare Minister Ghulam Nabi Azad announced an initiative that will significantly raise the salary of "doctors, specialists and para-medical staff" who elect to work in "rural, particularly far-flung and inaccessible areas," the Hindu reports.
Medical Devices

European Urology July Issue Reviews Prostate Screening Studies

The July issue of European Urology, the official journal of the European Association of Urology, features an editorial by Lars Holmberg comparing the results from the European Randomised Study of Screening for Prostate Cancer (ERSPC) with the results from the Prostate, Lung, Colorectal and Ovarian Cancer Screening Trial (PLCO) In the editorial, Professor Holmberg writes that "The studies illustrate that the price to pay for 20% reduction in prostate cancer deaths is high; overdiagnosis and overtreatment are great problems. The answers lie in improving the PSA test or finding biomarkers that effectively separate aggressive cancers from slow-growing ones. We identify some priorities in the discussion about PSA testing." Another article of interest in this issue is "Testosterone and Prostate Cancer: Revisiting Old Paradigms" by H. Isbarn et al. The notion that pathologic prostate growth, benign or malignant, can be stimulated by androgens is a commonly held belief - but one without scientific basis. In the article, Dr. Isbarn writes that, "We therefore conducted a Medline search to identify articles addressing the relationship between testosterone and the risk of prostate cancer development. Although large prospective studies addressing the long-term effect of testosterone treatment are needed to either refute or corroborate the hypothesis, the available literature strongly suggests that testosterone treatment neither increases the risk of prostate cancer diagnosis in normal men nor causes cancer recurrence in men who were successfully treated for prostate cancer." Next month, European Urology will publish the EAU position statement on screening for prostate cancer which takes into consideration the recent scientific information on randomised screening studies on prostate cancer (Schrç¶der et al, NEJM 2009). The EAU adopts the conclusions of the ERSPC study and recognises the benefit of screening in terms of mortality reduction, as well as the adverse effects of overdiagnosis and overtreatment of prostate cancers which could be quantified for the first time in the setting of a randomised screening study. Lindy Brouwer European Association of Urology


Add your comment:
Name:
Site address: http://
Your message:
Enter today\\\\'s date, 2 digits
(spam protection):

© Copyright 2009